Connection
Natalie McCall to Tacrolimus
This is a "connection" page, showing publications Natalie McCall has written about Tacrolimus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.212 |
|
|
|
-
Harris KJR, Ludtke EA, Goldberg B, McCall NN, Hewlett JC, Wilfong EM. Tacrolimus as first-line therapy in a US cohort of idiopathic inflammatory myopathies related interstitial lung disease. Rheumatology (Oxford). 2025 Dec 01; 64(SI):SI179-SI183.
Score: 0.212